Literature DB >> 15736190

Influence of asymmetric donor-receiver ion concentration upon transscleral iontophoretic transport.

S Kevin Li1, Yanhui Zhang, Honggang Zhu, William I Higuchi, Henry S White.   

Abstract

Recent in vitro and in vivo studies have suggested transscleral iontophoresis as a means for non-invasive drug delivery to the eye. However, there remains a lack of information of the iontophoretic transport behavior of the sclera. The objective of the present study was to investigate the effects of permeant concentration upon transscleral iontophoretic transport. Constant current direct current (DC) iontophoresis was conducted with rabbit sclera in vitro at permeant concentration ranging from 0.015 to 1.0 M in the donor chamber without background electrolyte at 0.4-4 mA (current density: 2-20 mA/cm2). PBS (0.15 M) was the receiver solution. Salicylate (SA) and tetraethylammonium (TEA) were the model ionic permeants, and mannitol was the neutral probe permeant. Conductivity experiments of SA and TEA solutions were performed to determine the effects of ion concentration upon SA and TEA electromobilities. Model simulations were carried out and compared with the experimental data. It was found that the fluxes of the ionic permeants increased linearly with the electric current but were relatively independent of their donor concentrations. Electric field-induced convective solvent flow (electroosmosis) in the sclera was observed to be from the anode to cathode, suggesting that the sclera is net negatively charge at neutral pH. For the studied permeants, electrophoresis was the main transport enhancing mechanism with electroosmosis as a secondary effect. No significant interaction between the permeants and sclera was observed that significantly altered electroosmosis in the membrane. Under the asymmetric donor and receiver conditions, the transference of the permeants could not be predicted by the concentrations of the ions in the donor and receiver chambers with the assumption of constant electric field in the membrane. The membrane ion concentrations were different from those in the chambers due to the requirement of charge neutrality in the membrane. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15736190     DOI: 10.1002/jps.20293

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Influence of permeant lipophilicity on permeation across human sclera.

Authors:  He Wen; Jinsong Hao; S Kevin Li
Journal:  Pharm Res       Date:  2010-08-24       Impact factor: 4.200

2.  Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging.

Authors:  Sarah A Molokhia; Eun-Kee Jeong; William I Higuchi; S Kevin Li
Journal:  Int J Pharm       Date:  2006-11-03       Impact factor: 5.875

3.  Iontophoretic transport across a multiple membrane system.

Authors:  Sarah A Molokhia; Yanhui Zhang; William I Higuchi; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

4.  Examination of barriers and barrier alteration in transscleral iontophoresis.

Authors:  Sarah A Molokhia; Eun-Kee Jeong; William I Higuchi; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-02       Impact factor: 3.534

5.  Iontophoresis of dexamethasone phosphate: competition with chloride ions.

Authors:  J-P Sylvestre; C Díaz-Marín; M B Delgado-Charro; R H Guy
Journal:  J Control Release       Date:  2008-07-06       Impact factor: 9.776

6.  International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics.

Authors:  Hermann A M Mucke; Peter Mucke; Eva Mucke
Journal:  Clin Ophthalmol       Date:  2009-06-02

7.  Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir.

Authors:  Qingfang Xu; Sarah A Ibrahim; William I Higuchi; S Kevin Li
Journal:  Int J Pharm       Date:  2008-11-11       Impact factor: 5.875

8.  Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab.

Authors:  He Wen; Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2012-12-04       Impact factor: 3.534

9.  Iontophoretic transport of charged macromolecules across human sclera.

Authors:  Poonam Chopra; Jinsong Hao; S Kevin Li
Journal:  Int J Pharm       Date:  2010-01-05       Impact factor: 5.875

10.  Enhanced transscleral lontophoretic transport with ion-exchange membrane.

Authors:  S Kevin Li; Honggang Zhu; William I Higuchi
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.